IMBB Researchers in collaboration with colleagues from Univ. of Geneva, Univ. of Crete and BRFAA discovered and validated distinct gene signatures conferring susceptibility and predicting the severity of Systemic Lupus Erythematosus. This landmark study identifies novel targets for personalized care.